Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy

Half-half PDT for active CSCR yielded improvements in both best-corrected visual acuity and CST. Half-half PDT is a safe alternative treatment option that is slightly less effective than half-dose, full-fluence PDT.

Authors

Institutions

Publication Details

Journal
Journal of VitreoRetinal Diseases
Published
2026-04-27
DOI
https://doi.org/10.1177/24741264261444276
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy

Matthew Tennant, Deven Deonarain, Amit V. Mishra, Graeme K. Loh
Journal of VitreoRetinal Diseases
Retinal Diseases and Treatments
article

Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy

Matthew Tennant, Deven Deonarain, Amit V. Mishra, Graeme K. Loh
article en

Abstract

Half-half PDT for active CSCR yielded improvements in both best-corrected visual acuity and CST. Half-half PDT is a safe alternative treatment option that is slightly less effective than half-dose, full-fluence PDT.

Journal of VitreoRetinal Diseases
Dalhousie University (CA), University of Alberta (CA), Greenlane Clinical Centre (NZ)
Good health and well-being
Openalex Percentile: Top 7%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.